Ambag, Ronelyn A.
HRN: 26-89-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2025
CEFUROXIME 500MG (TAB)
03/30/2025
04/06/2025
ORAL
500mg
BID
SP NSVD RMLE WITH EPISIORRAPHY
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes